278 related articles for article (PubMed ID: 23459468)
1. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder.
Olsson SK; Sellgren C; Engberg G; Landén M; Erhardt S
Bipolar Disord; 2012 Nov; 14(7):719-26. PubMed ID: 23030601
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
Holtze M; Saetre P; Engberg G; Schwieler L; Werge T; Andreassen OA; Hall H; Terenius L; Agartz I; Jönsson EG; Schalling M; Erhardt S
J Psychiatry Neurosci; 2012 Jan; 37(1):53-7. PubMed ID: 21693093
[TBL] [Abstract][Full Text] [Related]
4. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity.
Kegel ME; Johansson V; Wetterberg L; Bhat M; Schwieler L; Cannon TD; Schuppe-Koistinen I; Engberg G; Landén M; Hultman CM; Erhardt S
Psychiatry Res; 2017 Jan; 247():105-112. PubMed ID: 27886578
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder.
Sellgren CM; Kegel ME; Bergen SE; Ekman CJ; Olsson S; Larsson M; Vawter MP; Backlund L; Sullivan PF; Sklar P; Smoller JW; Magnusson PK; Hultman CM; Walther-Jallow L; Svensson CI; Lichtenstein P; Schalling M; Engberg G; Erhardt S; Landén M
Mol Psychiatry; 2016 Oct; 21(10):1342-50. PubMed ID: 26666201
[TBL] [Abstract][Full Text] [Related]
7. Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.
Wonodi I; Stine OC; Sathyasaikumar KV; Roberts RC; Mitchell BD; Hong LE; Kajii Y; Thaker GK; Schwarcz R
Arch Gen Psychiatry; 2011 Jul; 68(7):665-74. PubMed ID: 21727251
[TBL] [Abstract][Full Text] [Related]
8. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls.
Sellgren CM; Gracias J; Jungholm O; Perlis RH; Engberg G; Schwieler L; Landen M; Erhardt S
Transl Psychiatry; 2019 Jan; 9(1):37. PubMed ID: 30696814
[TBL] [Abstract][Full Text] [Related]
10. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder.
Olsson SK; Samuelsson M; Saetre P; Lindström L; Jönsson EG; Nordin C; Engberg G; Erhardt S; Landén M
J Psychiatry Neurosci; 2010 May; 35(3):195-9. PubMed ID: 20420770
[TBL] [Abstract][Full Text] [Related]
12. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.
Wonodi I; McMahon RP; Krishna N; Mitchell BD; Liu J; Glassman M; Hong LE; Gold JM
Schizophr Res; 2014 Dec; 160(1-3):80-7. PubMed ID: 25464917
[TBL] [Abstract][Full Text] [Related]
13. The kynurenine pathway in schizophrenia and bipolar disorder.
Erhardt S; Schwieler L; Imbeault S; Engberg G
Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology.
Afia AB; Vila È; MacDowell KS; Ormazabal A; Leza JC; Haro JM; Artuch R; Ramos B; Garcia-Bueno B
J Neuroinflammation; 2021 Sep; 18(1):198. PubMed ID: 34511126
[TBL] [Abstract][Full Text] [Related]
15. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.
Sathyasaikumar KV; Stachowski EK; Wonodi I; Roberts RC; Rassoulpour A; McMahon RP; Schwarcz R
Schizophr Bull; 2011 Nov; 37(6):1147-56. PubMed ID: 21036897
[TBL] [Abstract][Full Text] [Related]
16. Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.
Aoyama N; Takahashi N; Saito S; Maeno N; Ishihara R; Ji X; Miura H; Ikeda M; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Yoshida K; Iwata N; Inada T; Ozaki N
Genes Brain Behav; 2006 Jun; 5(4):364-8. PubMed ID: 16716206
[TBL] [Abstract][Full Text] [Related]
17. GRK3 deficiency elicits brain immune activation and psychosis.
Sellgren CM; Imbeault S; Larsson MK; Oliveros A; Nilsson IAK; Codeluppi S; Orhan F; Bhat M; Tufvesson-Alm M; Gracias J; Kegel ME; Zheng Y; Faka A; Svedberg M; Powell SB; Caldwell S; Kamenski ME; Vawter MP; Schulmann A; Goiny M; Svensson CI; Hökfelt T; Schalling M; Schwieler L; Cervenka S; Choi DS; Landén M; Engberg G; Erhardt S
Mol Psychiatry; 2021 Nov; 26(11):6820-6832. PubMed ID: 33976392
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.
Linderholm KR; Skogh E; Olsson SK; Dahl ML; Holtze M; Engberg G; Samuelsson M; Erhardt S
Schizophr Bull; 2012 May; 38(3):426-32. PubMed ID: 20729465
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV.
Douet V; Tanizaki N; Franke A; Li X; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):549-61. PubMed ID: 27072370
[TBL] [Abstract][Full Text] [Related]
20. Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.
Atlas A; Gisslén M; Nordin C; Lindström L; Schwieler L
Brain Behav Immun; 2007 Jan; 21(1):86-91. PubMed ID: 16603336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
